コンテンツへスキップ
Merck

主要文書

すべての文書を表示

HSP2MAG-63K

MILLIPLEX® Human Sepsis Panel

Configurable Human Sepsis 7-Plex Panel 2

ログインで組織・契約価格をご覧ください。

この商品について

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

製品名

MILLIPLEX® Human Sepsis Panel,

description

Configurable Human Sepsis 7-Plex Panel 2

Quality Segment

200

species reactivity

human

packaging

pkg of 1 ea

manufacturer/tradename

Milliplex®

assay range

accuracy: 87%
(MIP-1β), accuracy: 92%
(MIP-1α), accuracy: 95%
(Granzyme B), accuracy: 98%
(IL-8), standard curve range: 10-10,000 pg/mL
(IL-1α and MIP-1β), standard curve range: 195-200,000 pg/mL
(MMP-8), standard curve range: 2,930-3,000,000 pg/mL
(HSP70), standard curve range: 2-2,000 pg/mL
(Granzyme B), standard curve range: 5-5,000 pg/mL
(IL-8 and MIP-1β)

technique(s)

multiplexing: suitable

input

serum
cell culture supernatant(s)
plasma

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

General description

Sepsis or SIRS (systemic inflammatory response syndrome) results from infection, whether bacterial, viral, fungal, or parasitic. The pathogenesis of sepsis is very complex. Both an innate and acquired immune response to infection interrupts homeostasis with a shift of cytokine expression that increases immunosuppression. In addition, migration of the leukocytes in the inflamed tissues secretes a tissue factor leading to the formation of thrombin, also triggering the release of chemokines and adhesion molecules through endothelial cells. Severe sepsis occurs when hypotension or hypoperfusion to one or more organs leads to organ dysfunction, which, in turn, can cause septic shock, multiple organ dysfunction syndrome (MODS) and death.

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 7 analytes in human serum, plasma, and cell culture supernatants.

Analytes included: Granzyme B, HSP70, IL-1α, IL-8, MIP-1α, MIP-1β, MMP-8

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Features and Benefits

  • Immune Response Research Panel: Luminex® xMAP® platform simultaneously quantitates 7 critical immune response biomarkers (Granzyme B, HSP70, IL-1α, IL-8/CXCL8, MIP-1α/CCL3, MIP-1β/CCL4, MMP-8) for comprehensive sepsis immunology research.
  • Streamlined Sample Processing: Compatible with human serum, plasma, and cell/tissue culture supernatants using neat sample analysis - no dilution required, simplifying research protocols and minimizing sample handling errors.
  • Multi-Pathway Sepsis Research: Investigate cytotoxic T-cell responses (Granzyme B), cellular stress (HSP70), pro-inflammatory cytokines (IL-1α, IL-8), chemokine signaling (MIP-1α, MIP-1β), and tissue remodeling (MMP-8) in sepsis pathogenesis studies.
  • Comprehensive Immune Profiling: Simultaneously measure innate immune activation, adaptive immune responses, chemotactic signals, and tissue damage markers to understand complex sepsis immunopathology in research settings.
  • Translational Sepsis Research: Address critical research gaps in understanding sepsis progression from initial immune response through SIRS, severe sepsis, and potential progression to MODS in experimental studies.
  • Flexible Research Applications: Configure analyte selection for specific research questions and adapt to various experimental designs from mechanistic cell culture studies to clinical research sample analysis.

Legal Information

Luminex is a registered trademark of Luminex Corporation
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Still not finding the right product?

Explore all of our products under MILLIPLEX® Human Sepsis Panel

signalword

Danger

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

保管分類

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Please refer to KIT Component information

pdsc

Please refer to KIT Component information

prtr

Please refer to KIT Component information

fsl

Please refer to KIT Component information

ishl_indicated

Please refer to KIT Component information

ishl_notified

Please refer to KIT Component information

cart

キットコンポーネントの情報を参照してください

jan

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする